Following Julia Louis-Dreyfus' completion of treatment for breast cancer, it looks like team for her hit HBO series Veep are looking forward to getting back to work. Co-star Matt Walsh has spoken up about the status of the show's forthcoming seventh season, telling Entertainment Weekly that the... Read More > Other Links From TVGuide.com Veep Julia Louis-Dreyfus
NRA spokeswoman and right-wing radio host Dana Loesch attacked former Trump campaign spokeswoman Kayleigh McEnany as being “flat-chested” while McEnany was undergoing surgical treatment for a predisposition to breast cancer, said The New York Times on Saturday. In a profile about Loesch...
Researchers have discovered that the risk of death from breast cancer is twice as high for patients with high heterogeneity of the estrogen receptor within the same tumor as compared to patients with low heterogeneity. The study shows that the higher risk of death is independent of other known tumor markers and also holds true for Luminal A breast cancer.
A new study is helping to answer a pressing question among scientists of just how close mice are to people when it comes to researching cancer. The findings reveal how mice can actually mimic human breast cancer tissue and its genes, even more so than previously thought, as well as other cancers including lung, oral and esophagus.
(MIT Portugal Program) The project developed by the MIT Portugal PhD Student at the University of Minho Carlos Gonçalves, was considered the most innovative of the 9 projects incubated during 10 weeks by Startup Nano, a pioneer incubation...Show More Summary
(Karolinska Institutet) Researchers at Karolinska Institutet in Sweden have discovered that the risk of death from breast cancer is twice as high for patients with high heterogeneity of the oestrogen receptor within the same tumour as compared to patients with low heterogeneity. Show More Summary
(Springer) Individuals with Lynch syndrome, a genetic condition that has long been known to carry dramatically increased risk of colorectal cancer and uterine cancer, now also have an increased risk of breast cancer. This is the conclusion of a study in the journal Genetics in Medicine which is published by Springer Nature.
NEW YORK, NY (January 18, 2018)--Researchers at Columbia University Irving Medical Center and NewYork-Presbyterian have identified two new breast cancer genes. Having one of the genes--MSH6 and PMS2--approximately doubles a woman's risk...Show More Summary
Columbia University researchers have identified two new breast cancer genes that also cause Lynch syndrome.
(Queen Mary University of London) Screening the entire population for breast and ovarian cancer gene mutations, as opposed to just those at high-risk of carrying this mutation, is cost effective and could prevent more ovarian and breast cancers than the current clinical approach, according to research published today in the Journal of the National Cancer Institute.
Researchers have found a new way of halting the growth of breast cancer cells. The researchers explored a new way to starve cancer cells from their molecular energy source. They hope that their discoveries can be further developed into a new way of treating breast cancer, and possibly other types of cancer.
FASTER, PLEASE: Biologists’ new peptide could fight many cancers. “MIT biologists have designed a new peptide that can disrupt a key protein that many types of cancers, including some forms of lymphoma, leukemia, and breast cancer, need to survive. The new peptide targets a protein called Mcl-1, which helps cancer cells avoid the cellular suicide […]
Ryan Palmer couldn't wait for 2018 to arrive after year when wife faced breast cancer and he had shoulder surgery
MIT biologists have designed a new peptide that can disrupt a key protein that many types of cancers, including some forms of lymphoma, leukemia, and breast cancer, need to survive.
The newer images are more expensive, but it’s not yet clear if they are more effective in catching cancers that will kill.
A new study suggests breast cancer patients taking palbociclib/letrozole combination therapy should avoid foods rich in xenoestrogens.
U.S. regulators have approved the first drug aimed at women with advanced breast cancers caused by an inherited flawed gene. The Food and Drug Administration on Friday approved AstraZeneca PLC's Lynparza … Click to Continue »
The Food and Drug Administration on Friday cleared the first treatment for patients with advanced breast cancer caused by BRCA mutations, which are genetic defects that raise the risk of malignancies. The drug, called Lynparza, already is approved for certain patients with advanced ovarian cancer...